Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23924442 | 1.00 | SLC7A5 (0.46) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| SCHEMBL2367281 | 1.00 | SLC7A5 (0.46) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| SCHEMBL1867465 | 1.00 | SLC7A5 (0.46) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| SCHEMBL31000531 | 1.00 | SLC7A5 (0.46) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| SCHEMBL1867460 | 1.00 | SLC7A5 (0.46) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL5513561 | 0.95 | TSHR (0.45) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| SCHEMBL5324417 | 0.83 | USP2 (0.48) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| SCHEMBL5580345 | 0.83 | USP2 (0.48) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL2553076 | 0.81 | TSHR (0.56) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 | |
| D,L-Threo-3-Hydroxyaspartic Acid SCHEMBL5019049 | 0.81 | TSHR (0.56) | SLC7A5TSHRUSP2SLCO1B1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| US-20230365959-A1 | METHOD FOR IMPROVING THE STABILITY OF A COMPOSITION COMPRISING A FLAVIN-DEPENDENT LACTATE DEHYDROGENASE | KIKKOMAN CORPORATION (JP) | 2023-11-16 | — | — | US | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| EP-4223884-A1 | METHOD FOR IMPROVING STABILITY OF COMPOSITION CONTAINING FLAVIN-DEPENDENT LACTATE DEHYDROGENASE | Kikkoman Corporation (JP) | 2023-08-09 | — | — | EP | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | claimed |
| WO-2022071417-A1 | METHOD FOR IMPROVING STABILITY OF COMPOSITION CONTAINING FLAVIN-DEPENDENT LACTATE DEHYDROGENASE | キッコーマン株式会社 | 2022-04-07 | — | — | WO | claimed |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2021-04-08 | — | — | US | claimed |
| EP-3638284-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2020-04-22 | — | — | EP | claimed |
| CN-110891592-A | Cyclic peptides for protection against respiratory syncytial virus | 维罗米蒂克斯股份公司 | 2020-03-17 | — | — | CN | claimed |
| WO-2018229156-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2018-12-20 | — | — | WO | claimed |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VIROMETIX AG (CH) | 2026-05-21 | — | — | US | disclosed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | disclosed |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2026-01-29 | — | — | US | disclosed |
| EP-0724645-A1 | ANTIFUNGAL ANTIBIOTIC CEPACIDINE A | CHEIL FOODS & CHEMICALS, INC. (KR) | 1996-08-07 | — | — | EP | disclosed |
| WO-1995011310-A1 | ANTIFUNGAL ANTIBIOTIC CEPACIDINE A | CHEIL FOODS & CHEMICALS INC. (KR) | 1995-04-27 | — | — | WO | disclosed |
| WO-1992022316-A1 | BIOLOGICAL REGULATION OF MINERALIZATION | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 1992-12-23 | — | — | WO | disclosed |
| EP-0308983-A2 | NMR imaging with Mn(II) coordination compositions | SALUTAR, INC. (US) | 1989-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIP, LNPEP, CSTB | SLC7A5 2179/4885TSHR 2352/4885USP2 1775/4885 |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VSIR, LRBA, CD74 | SLC7A5 2164/4885TSHR 2459/4885USP2 2748/4885 |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | PHAX, TPX2, MLX | SLC7A5 192/4885TSHR 2172/4885USP2 3111/4885 |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIP, QPCT, QPCTL | SLC7A5 196/4885TSHR 1073/4885USP2 1530/4885 |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | QPCT, QPCTL, VIP | SLC7A5 277/4885TSHR 2209/4885USP2 1808/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | SLC7A5 37/4885TSHR 1606/4885USP2 1887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.